Biomarker-driven adjuvant targeted therapy for NSCLC-the ALCHEMIST trials

Bull Am Coll Surg. 2015 Sep;100(9):25-7.
No abstract available

MeSH terms

  • Biomarkers*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Clinical Trials as Topic
  • Humans
  • Lung Neoplasms / drug therapy*
  • Molecular Targeted Therapy*

Substances

  • Biomarkers